Eledon Pharmaceuticals In... (ELDN)

NASDAQ: ELDN · Real-Time Price · USD

3.31

0.03 (0.91%)

At close: May 02, 2025, 3:59 PM

3.27

-1.21%

After-hours: May 02, 2025, 04:35 PM EDT

Eledon Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	120K	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	374K	373K	195K	183K	182K	11K	22K	35K
Gross Profit	n/a	-374K	-373K	-195K	-63K	-182K	-11K	-22K	-35K
Operating Income	n/a	-43M	8.49M	-36.87M	-18.46M	-16.05M	-14.06M	-13.12M	-38.12M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-35.75M	-40.33M	-87.97M	-36.86M	-23.21M	-16.01M	-14.06M	-13.12M	-37.96M
Net Income	-35.32M	-40.33M	-87.5M	-34.51M	-22.81M	-17.88M	-14.06M	-13.12M	-37.96M
Selling & General & Admin	18.61M	12.69M	12.7M	13.13M	10.05M	6.06M	7.24M	11.1M	13.1M
Research & Development	51.96M	30.31M	27.08M	23.73M	6.13M	8.13M	6.82M	2.02M	25.02M
Other Expenses	n/a	n/a	462K	7K	79K	40K	-5K	5K	n/a
Operating Expenses	70.58M	43M	39.78M	36.87M	16.18M	14.18M	14.06M	13.12M	38.12M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	43M	39.78M	36.87M	16.18M	14.18M	14.06M	13.12M	38.12M
Income Tax Expense	-431K	n/a	-462K	-2.35M	-404K	1.87M	-5K	n/a	136K
Shares Outstanding (Basic)	48.54M	24.62B	14.29M	14.82M	1.45M	655.52K	500.3K	259.87K	21.26K
Shares Outstanding (Diluted)	485.44M	24.62M	14.29M	14.82M	1.45M	655.52K	500.3K	259.87K	21.26K
EPS (Basic)	-0.73	-0.00	-6.13	-2.33	-15.72	-27.27	-28.11	-50.47	-1.79K
EPS (Diluted)	-0.07	-1.64	-6.13	-2.33	-15.72	-27.27	-28.11	-50.47	-1.79K
EBITDA	-35.39M	n/a	-87.59M	-36.66M	-23.03M	-15.83M	-14.05M	-13.1M	-6.9M
EBIT	n/a	-43M	-87.97M	-36.86M	-23.21M	-16.01M	-14.06M	-13.12M	-6.93M
Depreciation & Amortization	n/a	43M	373K	195K	183K	182K	11K	22K	35K